Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PYRAZOLES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11Linked to original sources
PubMed2006

Reaction with dioxygen of a Cu(I) complex of 1-benzyl-[3-(2'-pyridyl)]pyrazole triggers ethyl acetate hydrolysis: acetato-/pyrazolato-, dihydroxo- and diacetato-bridged Cu(II) complexes.

A copper(I) compound [(L2)Cu(MeCN)2][ClO4] (1) containing a new bidentate N-donor ligand L2, 1-benzyl-[3-(2'-pyridyl)]pyrazole, derived from the condensation of HL1 [HL1 = 3-(2-pyridyl)pyrazole] and benzyl chloride, has been synthesized. Structural analysis reveals that in the copper(I) centre is coordinated by a pyridine and a pyrazole nitrogen from L2 and two MeCN molecules, providing a distorted tetrahedral geometry. Reaction of with dioxygen in N,N'-dimethylformamide (dmf) at 25 degrees C and subsequent workup with MeCO2Et afforded an acetato-/pyrazolato-bridged polymeric copper(II) compound [(mu-L1)Cu(mu-O2CMe)]n (2). Notably, the deprotonated form of HL(1) and MeCO2- have originated from debenzylation of L2 and hydrolysis of MeCO2Et, respectively. The structural analysis of reveals a near-planar {Cu2(mu-L1)2}2+ core unit in which two adjacent Cu(II) ions are bridged by the deprotonated N,N-bidentate pyridylpyrazole units of two L1 and each such {Cu2(mu-L1)2}2+ unit is bridged by MeCO2- in a monodentate bridging mode [Cu...Cu separations (A): 3.9232(4) pyrazolate bridge; 3.3418(4) acetate bridge], providing a polymeric network. Careful oxygenation of in MeCN led to the isolation of a dihydroxo-bridged dicopper(II) compound [{(L2)Cu(mu-OH)(OClO3)}2] (3). Interestingly, complex brings about hydrolysis of MeCO2Et under mild conditions (dmf, ca. 60 degrees C), generating a bis-mu-1,3-acetato-bridged dicopper(II) complex, [{(L2)Cu(dmf)(mu-O2CMe)}2][ClO4]2.dmf.0.5MeCO2H (4). Compounds and have {Cu2(mu-OH)2}2+ [Cu...Cu separation of 2.8474(9) A] and {Cu2(mu-O2CMe)2}2+ cores [Cu...Cu separation: 3.0988(26) and 3.0792(29) A (two independent molecules in the asymmetric unit)] in which each Cu(II) centre is terminally coordinated by L2. A rationale has been provided for the observed debenzylation of L2 and hydrolysis of MeCO(2)Et. The intramolecular magnetic coupling between the Cu(II) (S = 1/2) ions was found to be ferromagnetic (2J = 82 cm(-1)) in the case of , but antiferromagnetic for (2J = -158 cm(-1)) and (2J = -96 cm(-1)). Absorption and EPR spectroscopic properties of the copper(II) compounds have also been investigated.

Acetates↗
PubMed2006

The competition between acetate and pyrazolate in the formation of polynuclear Zn(II) coordination complexes.

Hydrated zinc(II) acetate reacts with pyrazole (Hpz) and, depending on the reaction conditions, forms different pyrazole-containing species, i.e. [[Zn(CH3COO)(mu-pz)(Hpz)]2] (1), [[Zn(CH3COO)2(Hpz)2.CH3COOH]] (2), [[Zn(mu-pz)2]n] (3), and [[Zn(mu-CH3COO)(mu-pz)]n] (4). Their structural models have been derived from single-crystal X-ray diffractometry as well as from less conventional ab-initio X-ray powder methods. All species contain tetrahedrally coordinated Zn(II) ions, with Zn-N and Zn-O bond distances close to 2.0 angstroms. The existence of the [Zn(mu-pz)]2 core in the species 1, 3 and 4 indicates the propensity for the formation, in the presence of pyrazolate ligands, of well-defined dinuclear entities (with Zn...Zn contacts in the range 3.6-3.8 angstroms). The latter can mutually interact, in the crystals, through either hydrogen-bonding of ancillary ligands (as in 1) or coordinative bonds (via acetates, as in 4, or by self-complementarity, as in 3). The interconversion paths among these species have been studied, employing chemical and thermal methods. In particular, the topotactic and quantitative transformation of 1 into 3 by moderate heating is likely based on a solid-state cooperative condensation mechanism of the dangling pyrazolates toward neighbouring zinc(II) ions, with concomitant acetic acid extrusion.

Journal Article↗
PubMed2006

Dicopper(II) complexes of a new pyrazolate-containing Schiff-base macrocycle and related acyclic ligand.

Dicopper(II) complexes of two new 3,5-disubstituted-pyrazole-based ligands, bis(quadridentate) macrocyclic ligand (L1)(2-) and bis(terdentate) acyclic ligand (L2)(-), were synthesised by Schiff base condensation of 3,5-diformylpyrazole and either one equivalent of 1,3-diaminopropane or two equivalents of 2-(2-aminoethyl)pyridine in the presence of one or two equivalents of copper(II) ions, respectively. Copper(II) acetate monohydrate was employed in the synthesis of [Cu(2)(L1)(OAc)(2)], [Cu(2)(L2)(H(2)O)(2)(OAc)(3)] and [Cu(II)(2)(L1)(NCS)(2)]; in the last of these one equivalent of NaNCS per copper(II) ion was also added. The fourth complex, [Cu(2)(L2)(NCS)(2)(DMF)]BF(4), was prepared using copper(II) tetrafluoroborate hexahydrate, along with two equivalents of NaOH and six of NaSCN. All four of these dimetallic complexes have been characterised by single crystal X-ray diffraction: the two macrocyclic complexes are the first such Schiff base complexes to be so characterised. A feature common to all four of the structures is bridging of the two copper(II) centres by the pyrazolate moiety/moieties. The structure determinations show that the coordination mode of the acetate groups in both [Cu(2)(L1)(OAc)(2)].2MeOH.H(2)O and [Cu(2)(L2)(H(2)O)(2)(OAc)(3)] is unidentate as had been tentatively predicted by analysis of the infrared spectra (DeltaOCO of 199 and 208 cm(-1), respectively). The magnetochemical studies of the macrocyclic complexes, over the temperature range 4-300 K, revealed strong antiferromagnetic coupling with J = -169 and -213 cm(-1) for [Cu(2)(L1)(OAc)(2)].2H(2)O and [Cu(II)(2)(L1)(NCS)(2)].DMF respectively. The J values have been discussed in relation to a published correlation involving the CuN(pyrazolate)N(pyrazolate) angles.

Journal Article↗
PubMed2002

A copper(II)-pyrazole complex cation with (macro)3 imposed symmetry.

The reaction of Cu(ClO(4))(2) x 6H(2)O, NaAsF(6) and excess pyrazole yields hexakis(pyrazole-kappa N(2))copper(II) bis(hexafluoroarsenate), [Cu(C(3)H(4)N(2))(6)](AsF(6))(2) or [Cu(pzH)(6)](AsF(6))(2) (pzH is pyrazole), (I). The analogous hexakis(pyrazole-kappa N(2))copper(II) hexafluorophosphate perchlorate complex, [Cu(C(3)H(4)N(2))(6)](PF(6))(1.29)(ClO(4))(0.71) or [Cu(pzH)(6)](PF(6))(1.29)(ClO(4))(0.71), (II), is obtained in a similar fashion, using KPF(6) in place of NaAsF(6). Both compounds contain the hitherto unknown [Cu(pzH)(6)](2+) complex cation, in which the copper(II) ion lies at the center of a regular octahedron of coordinated N atoms. The cation has crystallographically imposed -3 symmetry. The X-ray data indicate that the lack of the expected distortion can be accounted for by the presence of either static Jahn-Teller disorder or dynamic Jahn-Teller distortion.

Journal Article↗
PubMed2004

1-[4-(Methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole derivatives.

Three related compounds containing a pyrazole moiety with vicinal phenyl rings featuring a methylsulfonyl substituent are described, namely 3-methyl-1-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole, C17H16N2O2S, ethyl 1-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole-3-carboxylate, C19H18N2O4S, and 1-[4-(methylsulfonyl)phenyl]-3-[3-(morpholino)phenoxymethyl]-5-phenyl-1H-pyrazole, C27H27N3O4S. The design of these compounds was based on celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, in order to study the influence of various substituents on COX-2 and 5-lipoxygenase (5-LOX) inhibition.

Journal Article↗
PubMed1999

Synthesis of a novel series of imidazo[4,5-c]pyrazole derivatives and their evaluation as herbicidal agents.

Ever changing problems in agricultural weed control require periodic introduction of new herbicides. Imidazo[4,5-c]pyrazoles, which were considered of interest as potential herbicides, were synthesized and examined for the pre-emergence, post-emergence, and post-transplant control of weeds in rice against broadleaf and grass weed species. The data obtained suggest that some imidazo[4,5-c]pyrazoles have potential herbicidal activity against a wide range of weeds, with 5-methyl, 5-thiomethyl, and 5-unsubstituted derivatives being the most effective. No herbicidal activity was observed in the 5-methylsulfonylimidazo[4,5-c]pyrazole and imidazo[4,5-c]pyrazolone series.

Arabidopsis↗
PubMed1990

Non-steroidal antiinflammatory agents, II: Synthesis of novel pyrazole and pyrazoline derivatives of 4(3H)-quinazolinone.

Antiinflammatory and/or analgesic activities have been ascribed to compounds containing the 4(3H)-quinazolinone or pyrazole moiety. Continuation to the previous work in the field of the synthesis of non-steroidal antiinflammatory 4(3H)-quinazolinones, the present investigation deals with the synthesis of new compounds having the pyrazole or pyrazoline and 4(3H)-quinazolinone moieties in one molecule, hoping that such combination might improve their antiinflammatory activity. alpha,beta-unsaturated ketones when treated with hydrazine hydrate achieve cyclization to the corresponding pyrazoline derivatives, whereas, when arylhydrazines are used, pyrazole derivatives are formed.

Animals↗
PubMed1995

Pyrazoles as potential histamine H3-receptor antagonists.

In search of structure-activity relationships among histamine H3-receptor antagonists, the imidazole ring of known H3-receptor antagonists was replaced by different heteroaromatic ring systems. Thus, pyrazoles with ether (4,5) and carbamate (6,7) moieties as functional groups were synthesized. Reaction of the hydrochloride of 4-(3-hydroxypropyl)pyrazole (1) with phenyl or benzyl isocyanates mainly gave the carbamates 6 and 7, whereas a similar reaction with 1 as the free base furnished the N-carbamoylpyrazoles 8 and 9. The bifunctional pyrazoles 10 and 11 were formed as by-products. The compounds obtained did not show significant H3-receptor antagonist activity in vitro (rat brain cortex) or in vivo (mouse brain). These results demonstrate the importance of the imidazole moiety for H3-receptor antagonists. The new compounds were also screened for H1-receptor antagonist activity on the isolated guinea-pig ileum and for H2-receptor antagonist activity on the isolated spontaneously beating guinea-pig right atrium. The substances showed only weak antagonistic activity at both histamine receptors H1 and H2.

Animals↗
PubMed1978

Heterocyclic tricycles as potential CNS agents I: 4-aminoalkylindeno[1,2-c]pyrazoles.

Series of 4-(3-dimethylaminopropyl)-4-hydroxyindeno[1,2-c]pyrazoles and 4-(1-methyl-4-piperidyl)-4-hydroxyindeno[1,2-c-]pyrazoles were synthesized and identified. The compounds were evaluated as potential CNS agents using spontaneous and forced motor activity in mice as an initial test. 2-Ethyl-3-methyl-4-(1-methyl-4-piperidyl)-4-hydroxyindeno[1,2-c]pyrazole possessed significant biological activity.

Animals↗
PubMed1992

Synthesis and anti-inflammatory activity of fluorinated phenyl styryl ketones and N-phenyl-5-substituted aryl-3-p-(fluorophenyl) pyrazolins and pyrazoles.

Various N-phenyl-5-substituted aryl-3-p-(fluorophenyl) pyrazolins and pyrazoles were synthesized by cyclization of the corresponding 4-(fluorophenyl) styryl and 4-(fluorophenyl) dibromostyryl ketones. These compounds were characterized by elemental analysis and UV, infrared, and nuclear magnetic spectral data. All substituted p-(fluorophenyl) styryl ketones [250 mg/kg orally (po)] possessed anti-inflammatory activity, as reflected by their ability to provide protection (51-70%) against carrageenin-induced edema in rat paw. Indomethacin (10 mg/kg, po) and dehydrozingerone (70 mg/kg, po), used as standard reference drugs, provided 97 and 60% protection, respectively. All compounds (0.20 mM) showed ability to denature bovine serum albumin, as observed in in vitro inhibition studies. Inhibition ranged from 7 to 59% for substituted p-(fluorophenyl) styryl ketones and from 12 to 21% for pyrazoles. No correlation was found between the anti-inflammatory activity of p-(fluorophenyl) styryl ketones or substituted pyrazoles and their effectiveness at inhibiting bovine serum albumin denaturation. The low toxicity of p-(fluorophenyl) styryl ketones was reflected by the dose that was lethal in 50% of the cases tested (2000-2500 mg/kg).

Animals↗
PubMed1985

Endogenous acetaldehyde in rats. Effects of exogenous ethanol, pyrazole, cyanamide and disulfiram.

Male Long-Evans rats consumed the alcohol and aldehyde dehydrogenase inhibitors pyrazole, cyanamide or disulfiram, for 6 days. No endogenous blood acetaldehyde could be detected in controls and pyrazole treated rats, endogenous blood concentrations up to 2-5 nmoles/ml were, however, measured in the cyanamide and disulfiram-treated animals. Other rats received daily ethanol gastric intubations in addition to the consumption of the inhibitors. Little or no acetaldehyde was detected in the controls and pyrazole treated animals during acute ethanol intoxication or on the subsequent days. High blood levels (200-500 nmoles/ml) were observed in the rats consuming cyanamide and disulfiram, and concentrations up to 10-12 nmoles/ml were still found on the following day after all the ethanol had been eliminated. This acetaldehyde and the endogenous acetaldehyde could only be observed with the hemolyzation method in which blood hemolyzates were directly heated prior to headspace GC analysis; none was detected if blood proteins were first precipitated and removed with perchloric acid. It is suggested that aldehyde dehydrogenase inhibitors elevate endogenous concentrations of bound acetaldehyde and that exogenous ethanol increases this form of acetaldehyde.

Acetaldehyde↗
PubMed1987

An investigation of the metabolism of N-nitroso-N-methylaniline by phenobarbital- and pyrazole-induced Sprague-Dawley rat liver and esophagus derived S-9.

The metabolism and mutagenicity of the esophageal carcinogen N-nitroso-N-methylaniline (NMA) was studied using hepatic and esophageal 9000 X g supernatant (S-9) preparations from Sprague-Dawley rats induced with pyrazole and phenobarbital. Only pyrazole-induced hepatic S-9 was able to dose-dependently activate NMA to a mutagen in the Ames assay and specifically in Salmonella typhimurium TA1537. NMA in the presence of phenobarbital-induced S-9 gave a very weak non-dose dependent mutagenic response. Metabolism of NMA by the two induced hepatic and esophageal S-9 fractions yielded aniline and N-methylaniline (MA). Phenobarbital-induced S-9 from both tissues also afforded phenol, while none was found with the pyrazole-induced preparations. Phenol formation presumably arose from the direct oxidative demethylation of NMA via a benzenediazonium ion (BDI) intermediate. The results indicate that an important metabolic pathway for NMA, with both inducing agents, entails an initial denitrosation to yield MA, which in turn rapidly undergoes oxidative demethylation to aniline. The conversion of NMA to phenol also suggests that direct demethylation of NMA in the phenobarbital-induced system is an important metabolic pathway.

Animals↗
PubMed2004

Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.

A series of N1 and C5 substituted cycloalkyl and C5 4-methylphenyl analogues of the N-(piperidin-1-yl)-4-methyl-1H-pyrazole-3-carboxamide class of cannabinoid ligands were synthesized. The analogues were evaluated for CB1 and CB2 receptor binding affinities and receptor subtype selectivity. The effects of pyrazole substitution on ligand conformation and as such receptor affinities was not readily apparent; therefore, the geometries of the N1 and C5 substituents relative to the pyrazole ring were studied using high field NMR spectroscopy and systematic molecular mechanics geometry searches. An analysis of the relative ring geometries and functional group orientations provides new insight into the structural requirements of the CB1 and CB2 ligand binding pocket.

Animals↗
PubMed2006

Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.

The synthesis of a series of 3-(4-chlorophenyl)-[1,2-c]pyrazol(in)es substituted with benzenesulfonamide, N1,N3-disubstituted sulfonylurea, sulfonylthiourea pharmacophores, and some derived thiazolidinone and thiazoline ring systems is described. All the newly synthesized target compounds were subjected to the NCI-in vitro disease-oriented antitumor screening to be evaluated for their antitumor activity. Eight compounds namely; 2-4, 7, 8, 10, 13, and 16; showed promising broad spectrum antitumor activity against most of the tested subpanel tumor cell lines (GI50 < 100 microM). Compound 3, 4-(3-(4-chlorophenyl)-4H-indeno[1,2-c]pyrazol- 2-yl)-benzenesulfonamide; although it did not show the highest growth inhibitory value (GI50 (MG-MID) 13.2 microM), it proved to be the most active analog in this study with the highest cytostatic and cytotoxic potentials (TGI and LC50 (MG-MID) concentrations of 33.1 and 66.1 microM, respectively). In general, the oxidized pyrazoles displayed better antitumor activity than their parent pyrazoline analogs, whereas the benzenesulfonamides and the N1, N3-disubstituted sulfonylureas showed significant better antitumor spectrum than the sulfonylthioureido and the derived thiazole analogs.

Antineoplastic Agents↗
PubMed2006

Insecticidal lead identification by screening benzopyrano[4,3-c] pyrazol-3(2H)-ones library constructed from multiple-parallel synthesis under microwave irradiation.

A rapid library-generation via liquid-phase multiple-parallel synthesis of 2-(substituted)benzyl-1-benzopyrano[4,3-c]pyrazol-3(2H)-ones, bearing two points of diversity, under microwave irradiation was successfully performed using chromenone-3-carboxylic acids as starting materials. Compared to an identical library generated by conventional parallel synthesis, microwave-assisted parallel synthesis dramatically decreased reaction times from an average of 16h to 13min, and the yields of products and intermediates were improved in most cases. A bioassay indicated that the compounds of the library exhibited excellent insecticidal activity against T. cinnabarinus at the dosage of 250mgL(-1), and some compounds still exhibited insecticidal activity when the dosage was reduced to 50mgL(-1). This shows that 2-(substituted) benzyl-1-benzopyrano[4,3-c]pyrazol-3(2H)-ones might be used as lead structures for further optimization. To our knowledge, this is the first report about the application of solution-phase multiple-parallel synthesis under microwave irradiation to construct libraries of benzopyrano-[4,3-c]pyrazol-3(2H)-ones with insecticidal activity. The coupling of microwave technology with liquid-phase parallel synthesis constitutes a novel and particularly attractive avenue for the rapid generation of structurally diverse libraries for lead discovery.

Animals↗
PubMed2004

Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

We have expanded our previously reported series of pyrazole-based inhibitors of the TGF-beta type I receptor kinase domain (TbetaR-I) to now include new 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole analogues. Limited examination of the SAR of this new series in both enzyme and cell based in vitro assays has revealed selectivity differences with respect to p38 MAP kinase (p38 MAPK) depending on the nature of the 'warhead' group on the dihydropyrrolopyrazole ring. As with our original pyrazole series, phenyl substituents tended to show greater selectivity against p38 MAPK than those comprised of the quinoline-4-yl moiety. We have also achieved co-crystallization and X-ray analysis of compounds 3 and 15, two potent examples of this new series, with the TbetaR-I receptor kinase domain.

Activin Receptors, Type I↗
PubMed2005

Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues.

The antimalarial activity of chloroquine-pyrazole analogues, synthesized from the reaction of 1,1,1-trifluoro-4-methoxy-3-alken-2-ones with 4-hydrazino-7-chloroquinoline, has been evaluated in vitro against a chloroquine resistant Plasmodium falciparum clone. Parasite growth in the presence of the test drugs was measured by incorporation of [(3)H]hypoxanthine in comparison to controls with no drugs. All but one of the eight (4,5-dihydropyrazol-1-yl) chloroquine 2 derivatives tested showed a significant activity in vitro, thus, are a promising new class of antimalarials. The three most active ones were also tested in vivo against Plasmodium berghei in mice. However, the (pyrazol-1-yl) chloroquine 3 derivatives were mostly inactive, suggesting that the aromatic functionality of the pyrazole ring was critical.

Animals↗
PubMed2006

Two new scorpionates vanadium haloperoxidases model complexes: synthesis and structure of VO(O2)(pzH)(HB(pz)3) and VO(O2)(pzH)(B(pz)4) (pzH = pyrazole(C3H4N2)).

Using vanadate, poly(1H-pyrazol-1-yl)borate and pyrazole as starting materials, two new neutral peroxovanadium(V) complexes with poly(1H-pyrazol-1-yl)borate, VO(O(2))(pzH)(HB(pz)(3))(1) and VO(O(2))(pzH)(B(pz)(4))(2), were synthesized successfully. Both complexes were characterized by elemental analysis, IR, UV-vis and NMR spectra. And the structure of complex 1 was determined by X-ray diffraction, which is somewhat relevant for haloperoxidase enzymes. Cytotoxic effects also are discussed on 3T3 cell proliferation. In the concentration range (0.1-100mumol), both complexes have an inhibiting cellular proliferation effect. When the cells cultivated with the complexes at high dose, the toxicity effect of both complexes is more and more predominant.

Magnetic Resonance Spectroscopy↗